Your browser doesn't support javascript.
loading
Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor Vasculature.
Gilles, Maud-Emmanuelle; Maione, Federica; Cossutta, Mélissande; Carpentier, Gilles; Caruana, Laure; Di Maria, Silvia; Houppe, Claire; Destouches, Damien; Shchors, Ksenya; Prochasson, Christopher; Mongelard, Fabien; Lamba, Simona; Bardelli, Alberto; Bouvet, Philippe; Couvelard, Anne; Courty, José; Giraudo, Enrico; Cascone, Ilaria.
Affiliation
  • Gilles ME; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
  • Maione F; Laboratory of Transgenic Mouse Models, Candiolo Cancer Institute - FPO, IRCCS, Candiolo (TO), Italy.
  • Cossutta M; Department of Science and Drug Technology, University of Torino, Torino, Italy.
  • Carpentier G; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
  • Caruana L; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
  • Di Maria S; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
  • Houppe C; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
  • Destouches D; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
  • Shchors K; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
  • Prochasson C; Swiss Institute for Experimental Cancer Research (ISREC), EPFL SV ISREC, Station 19, Lausanne, Switzerland.
  • Mongelard F; Department of Pathology, Bichat Hospital APHP DHU UNITY and University of Paris Diderot, Paris, France.
  • Lamba S; University of Lyon, Ecole normale Supérieure de Lyon, Cancer Research Center of Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, Lyon, France.
  • Bardelli A; Department of Oncology, University of Torino, Candiolo (TO), Italy.
  • Bouvet P; Department of Oncology, University of Torino, Candiolo (TO), Italy.
  • Couvelard A; Candiolo Cancer Institute-FPO, IRCCS, Candiolo (TO), Italy.
  • Courty J; University of Lyon, Ecole normale Supérieure de Lyon, Cancer Research Center of Lyon, Cancer Cell Plasticity Department, UMR INSERM 1052 CNRS 5286, Centre Léon Bérard, Lyon, France.
  • Giraudo E; Department of Pathology, Bichat Hospital APHP DHU UNITY and University of Paris Diderot, Paris, France.
  • Cascone I; University of Paris Est (UPEC), ERL-CNRS 9215, Laboratory of Growth, Reparation and Tissue Regeneration (CRRET), UPEC, Créteil, France.
Cancer Res ; 76(24): 7181-7193, 2016 12 15.
Article in En | MEDLINE | ID: mdl-27754848
Search on Google
Database: MEDLINE Main subject: Pancreatic Neoplasms / Peptides / Phosphoproteins / RNA-Binding Proteins / Carcinoma, Pancreatic Ductal / Neovascularization, Pathologic Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2016 Type: Article Affiliation country: France
Search on Google
Database: MEDLINE Main subject: Pancreatic Neoplasms / Peptides / Phosphoproteins / RNA-Binding Proteins / Carcinoma, Pancreatic Ductal / Neovascularization, Pathologic Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2016 Type: Article Affiliation country: France